Last updated: March 27, 2024
Sponsor: Louise Penzenstadler
Overall Status: Active - Recruiting
Phase
N/A
Condition
Opioid Use Disorder
Mood Disorders
Stimulant Use Disorder
Treatment
standard inpatient treatment
Hospital-like treatment in patients' home
Clinical Study ID
NCT05563363
not yet available
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Substance use disorder
- age 18 or above
- sufficient french language skills
- competent subjects
- consent to randomization progress
Exclusion
Exclusion Criteria:
- organic brain disease or developmental disorder
- non voluntary admission
- severe somatic comorbidity
- History of complicated substance withdrawal
- acute suicidal ideation
- aggressive behavior
- acute psychiatric disease such as mania or psychosis
- distance to center (must be reachable within 60 minutes)
Study Design
Total Participants: 40
Treatment Group(s): 2
Primary Treatment: standard inpatient treatment
Phase:
Study Start date:
December 01, 2022
Estimated Completion Date:
June 30, 2025
Connect with a study center
Geneva University Hospital
Geneva,
SwitzerlandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.